Aptorum Group Ltd - Ordinary Shares - Class A

NASDAQ:APM  
2.44
+0.07 (+2.95%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Aptorum Group Ltd - Ordinary Shares - Class A Stock, NASDAQ:APM

17 Hanover Square, Guangdong Investment Tower, London, Greater London W1S 1BN
Cayman Islands
Phone: +44.20.8092.9299
Number of Employees: 26

Description

Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop drug molecules and certain technologies for the treatment and diagnosis of human disease conditions. The Non-Therapeutics segment encompasses diagnostics projects including a novel molecular-based rapid pathogen identification and detection diagnostics, AML Clinic, and sale of natural supplements. Its pipeline include Smart-Act, Acticule, RPIDD, Nativus, and Claves series. The company was founded by Ian Huen on September 13, 2010 and is headquartered in London, the United Kingdom.